Literature DB >> 24265580

Human Ring Chromosomes - New Insights for their Clinical Significance.

Rs Guilherme1, E Klein, Ab Hamid, S Bhatt, M Volleth, A Polityko, A Kulpanovich, A Dufke, B Albrecht, S Morlot, L Brecevic, Mb Petersen, E Manolakos, N Kosyakova, T Liehr.   

Abstract

Twenty-nine as yet unreported ring chromosomes were characterized in detail by cytogenetic and molecular techniques. For FISH (fluorescence in situ hybridization) previously published high resolution approaches such as multicolor banding (MCB), subcentromere-specific multi-color-FISH (cenM-FISH) and two to three-color-FISH applying locus-specific probes were used. Overall, ring chromosome derived from chromosomes 4 (one case), 10 (one case), 13 (five cases), 14, (three cases), 18 (two cases), 21 (eight cases), 22 (three cases), X (five cases) and Y (one case) were studied. Eight cases were detected prenatally, eight due developmental delay and dysmorphic signs, and nine in connection with infertility and/or Turner syndrome. In general, this report together with data from the literature, supports the idea that ring chromosome patients fall into two groups: group one with (severe) clinical signs and symptoms due to the ring chromosome and group two with no obvious clinical problems apart from infertility.

Entities:  

Keywords:  Fluorescence in situ hybridization (FISH); Genotype-phenotype correlations; Ring chromosomes

Year:  2013        PMID: 24265580      PMCID: PMC3835292          DOI: 10.2478/bjmg-2013-0013

Source DB:  PubMed          Journal:  Balkan J Med Genet        ISSN: 1311-0160            Impact factor:   0.519


INTRODUCTION

It is common sense that ring chromosomes result from two terminal breaks on both chromosome arms followed by fusion of the broken ends, leading to the loss of genetic material. Alternatively, they can be formed by telomere-telomere fusion without deletion [ 1 ] or the so-called McClintock mechanism [ 2 ] . Also more complex mechanisms of ring chromosome formation have been proposed [ 3 , 4 ] . Ring chromosomes are also observed as small supernumerary marker chromosomes (sSMC) [ 5 , 6 ] , however, their formation seems to be completely different from that of ring chromosomes in a numerically normal karyotype [ 7 , 8 ] . Phenotypes associated with ring chromosomes can be highly variable, since in addition to the primary deletion associated with ring formation, secondary loss or gain of material may occur due to ring chromosome instability. It has also been reported that the phenotype of ring chromosome patients can overlap that of the deletion of both ends of the respective chromosome syndromes without ring formation. Moreover, there have also been numerous reports on ring chromosomes without clinical consequences, apart from possible infertility, if no relevant genetic material was lost due to ring chromosome formation [ 1 ] . Here we report ring chromosomes observed in 29 patients with (severe) clinical problems, and/or solely infertility, evaluated by cytogenetic and molecular techniques.

MATERIALS AND METHODS

Twenty-nine cases with ring chromosomes were studied for different clinical reasons (see Table 1 ). Eight cases were detected prenatally (amniocytes studied), eight due developmental delay and dysmorphic signs, and nine in connection with infertility and/or Turner syndrome; in four cases the reason for the study was not transmitted to the laboratory at Jena, Germany (peripheral blood studied). Chromosomes were prepared according to standard procedures. The cases were studied using standard banding cytogenetics and by means of FISH (fluorescence in situ hybridization). Previously published high resolution approaches such as multicolor banding (MCB) [ 9 , 10 ] , subcentromere-specific multicolor-FISH (cenM-FISH) [ 6 ] and two to three-color-FISH applying locus-specific and/or commercially available centromere specific probes (Abbott/Vysis, Wiesbaden, Germany and/or Kreatech, Amsterdam, The Netherlands) were used. Locus-specific probes and also commercial probes, such as subtelomeric ones (Abbott/Vysis) or bacterial artificial chromosome (BAC) probes, were applied. Labeling and application of the probes was done according to the manufacturer’s instructions or as reported [ 11 ] .
Table 1.

Details on the 29 studied ring chromosome cases according to their chromosomal origin, karyotype, age at diagnosis and clinical signs. [DD: developmental delay; DS: dysmorphic signs; IUGR: intrauterine growth retardation; NA: not available; TOP: termination of pregnancy; y = year(s)]

Case # Chromosome of Origin Karyotype Age at Diagnosis Clinical Signs

R-1 4 46,XX,r(4)(p16.2q34.1)[14]/ 5 years DDDS
46,XX,r(4)(::p11->q32.1::q32.1->p11::)[4]/
46,XX,r(4)(p11q35.1)[3]/
45,XX,-4[3]/
46,XX,r(4)(::p16.2->q35.1::q12->q35.1::)[2]/
46,XX,r(4)(::p16.2->q27::q11->q32.1::)[2]/
47,XX,r(4)(::p16.2->q35.1::q12->q35.1::),+r(4)(p11q35.1)[1]/
47,XX,-4,+r(4)(::p16.2->q27::q11->q32.1::)x2[1]/
47,XX,-4,+r(4)(::p11->q32.1::q32.1->p11::)x2[1]/
47,XX,-4,r(4)(::p16.2->q34.1::)x2[1]/
46,XX,r(4)(::p16.2->q34.1::p16.2->q34.1::)[1]/
46,XX,r(4)(p16.2q35.1)[1]/
45,XX,-4,-14,+der(4)t(4;14)(q32.1;q11.2)[1]

R-2 10 47,XY,del(10)(q10q25.3),+r(10)(q10q25.3)[23]/ 5 years DDDS
46,XY,del(10)(q10q25.3)[6]/
47,XY,del(10)(q10q25.3),+r(10)(::q10->q25.3::q10->q25.3::)[1]

R-3 13 46,XY,r(13)(p11.2q33.3∼34)[9]/ prenatal IUGR, DS TOP
46,XY,r(13)(::p11.2q33.3∼34::p11.2q33.3∼34::)[1]

R-4 13 46,XX,r(13)(p11.1q33.3)[13]/ 6 years DD, DS microcephaly dwarfism
46,XX,r(13,13)(::p11.1->q33.3::p11.1->q33.3::)[1]/
45,XX,-13[1]

R-5 13 46,XX,r(13)(p11q32.3)[93%]/ adult DDDS
46,XX,r(13)(::p11->q32.3::p11->q32.2::)[7%]

R-6 13 45,XX,-13[50]/ prenatal IUGRTOP
46,XX,r(13)(p11.1q33∼34)[50]

R-7 13 46,XY,r(13)(p1?2q34) NA NA

R-8 14 46,XX,r(14)(::p12->q32.2::q32.2->q23::)[20]/ newborn DDDS
46,XX,r(14)(p12q32.2)[4]/
46,XX,del(14)(q21)[1]/
46,XX[1]

R-9 14 46,XY,r(14)(p13q32.2)[82]/ 1 year DDDS
45,XY,-14[18]

R-10 14 46,XX,r(14)(p1?3q24.3) prenatal DSTOP

R-11 18 46,XX,r(18)(p11.1q12.3∼21.1)[7]/ prenatal NA
der(18)(:p11.1->q12.3∼21.1:)[12]

R-12 18 46,XX,r(18)(p11.21q23)[7]/ prenatal hydrocephalus TOP
45,XX,-18[3]

R-13 21 45,XX,-21[50%]/ 11 years DDDS
46,XX,r(21)(p12q22.3)[30%]/
46,XX,del(21)(q22.3)[20%]

R-14 21 46,XX,r(21)(p1?3q22.1)[64]/ 1 year DDDS
45,XX,-21[26]/
46,XX[10]

R-15 21 46,XY,r(21)(::p11->q22::p11q22::)[10]/ prenatal DSTOP
46,XY,r(21)(::p11->q22::)[7]/
45,XY,-21[7]/
46,XY,der(21)(:p11->q22::p11->q22:)[2]/
46,XY,der(21)(:p11->q22:)[1]/
46,XY,r(21)(::p11->q22::p11q2?1::)[1]/
46,XY,der(21)(:q22->p11::p11->q22:)[1]/
47,XY,r(21)(::p11->q22::),+r(21,21)(::p11->q22::p11q22::)[1]

R-16 21 46,XY,r(21)(p12q22.3)[23]/ prenatal NA
46,XY,r(21;21)(::p12->q22.3::p12->q22.3::)[4]/
45,XY,-21[2]/
46,XY,r(21)(p12q21)[1]

R-17 21 46,XY,r(21)(p1?2q22.3)[21]/ 32 years infertility
46,XY,del(21)(:p1?2->q22.3:)[13]/
46,XY,r(21)(::p1?2->q22.3::q22.3->p1?2::p1?2->q22.3::q22.3->p1?2::)[1]

R-18 21 46,XY,r(21)(p11.1q22.?2)[9]/ NA NA
46,XY,r(21;21)(::p11.1->q22.?2::p11.1->q22.?2::)[1]

R-19 21 46,XN,der(21)(:q11.2->p11.1∼11.2::p11.1∼11.2->q22.3:)[8]/ prenatal NA
46,XN,del(21)(:p11.1∼11.2->q22.3:)[7]/
46,XN,r(21)(::p11.1∼11.2->q22.3::)[4]/
45,XN,-21[1]

R-20 21 46,XX,r(21)(::p11.2->q22.3::)[33]/ 17 years premature ovarian insufficiency
46,XX,r(21)(::p11.2->q22.3::p11.2->q22.3::)[5]/
47,XX,r(21)(::p11.2->q22.3::),+del(21)(p11.2:)[1]/
46,XX[1]

R-21 22 46,XN,r(22)(p1?2q1?3) 26 y infertility

R-22 22 46,XY,r(22)(p11q13.3) NA NA

R-23 22 46,XX,r(22)(::p12->q11.1::p11.1->q11.1::q11.1->p12::)[3]/ NA NA
46,XX,der(22)(:q11.1->p12::p12->q11.1:)[2]/
46,XX,r(22)(::p12>q11.1::)[2]/
46,XX,r(22)(::p11.1->q11.1::p11.1->q11.1::)[1]

R-24 X 45,X[56]/ 16 y Turner syndrome
46,X,r(X)(p11.1q24)[44]

R-25 X 45,X[19]/ 40 y infertility
46,X,r(X)(p11.2q13.?1)[11]

R-26 X 45,X[46]/ 30 y Turner syndrome
46,X,r(X)(p11.?22q13.3)[4]/
47,X,r(X)(p11.?22q13.3)x2[1]

R-27 X 45,X[17]/ 28 y infertility
46,X,r(X)(p11.23q28)[7]

R-28 X 45,X[70%]/ 26 y infertility
46,X,r(X)(p22.1∼22.2->q21.1)[27%]/
46,X,r(X)(::p22.1∼22.2->q21.1::q21.1->p22.1∼22.2::)[2]/
47,X,-X,+r(X)(::p22.1∼22.2->q21.1::q21.1->p22.1∼22.2::)x2[1]

R-29 Y 45,X[?%]/46,X,r(Y)(::p11.3->q11.2?3::q11.2?3->p11.3::)[?%] adult infertility

RESULTS AND DISCUSSION

In 29 cases with ring chromosomes, the chromosomal origin and content could be determined using molecular cytogenetics. The rings were derived from chromosome 4 (one case), 10 (one case), 13 (five cases), 14, (three cases), 18 (two cases), 21 (eight cases), 22 (three cases), X (five cases) and Y (one case). The exact breakpoints and mosaic states are summarized in Table 1 and examples of the FISH results are shown in Figure 1 . In the following data, the obtained results were compared with the literature by chromosomal origin; afterwards, the chromosomal imbalances were analyzed, and finally, a conclusion was drawn.
Figure 1.

Representative results for the molecular cytogenetic characterization of the studied ring chromosomes. A) In case R-7, a ring chromosome derived from chromosome 13 [r(13)] was present as well as a normal chromosome 13 (#13); breakpoints were characterized by MCB as 13p1?2 and 13q34. B) Application of a subtelomeric probe for chromosome 13qter (subtel 13qter) together with a centromeric probe for chromosomes 13 and 21 (cep 13/21) confirmed a partial deletion in 13qter. C) Application of a centromeric probe for chromosomes 13 and 21 (cep13/21) with a subtelomeric probe for chromosome 21qter (subtel 21qter) in combination with a subcentromeric probe in 21q11.2 revealed the presence of three derivatives of a chromosome 21 in case R-23; a ring [r(21)], a double ring [dr(21)] and a shortened derivative of chromosome 21 [der(21)] were observed. For final karyotype results, see Table 1 .

Analyzed Rings by Chromosomal Origin

Numerous cases for have been reported previously [ 12 – 14 ] . Interestingly, those cases fall into two cytogenetic groups: one group where the ring is stable and the other group where it is unstable within the studied cells, as in case R-1. Further studies are necessary to rule out where this instability comes from, and what the clinical impact is. To the best of our knowledge, no clinically normal ring chromosome 4 case has yet been reported. In case R-2, the first ever seen balanced ring formation involving formed by the McClintock mechanism [ 2 ] is reported. The rearrangement was connected with clinical problems, as the ring was lost in ∼20.0% of the cells. Ring chromosomes derived from chromosome 10 are rare (only about 10 cases) and were recently reviewed [ 15 ] . Martin et al. [ 16 ] suggested the existence of a syndrome and gave an incidence of 1/58,000 in live births. Here, five cases with ring chromosomes 13 were studied (R-3 to R7), all of them were clinically abnormal. Similarly to chromosome 13 derived rings, is also suggested as a specific syndrome [ 17 ] . In concordance with the literature, all three ring chromosome 14 cases studied here (R-8 to R10) had an abnormal phenotype. were present in the prenatally studied cases R-11 and R-12. Here too, a recognizable syndrome was suggested [ 18 ] . Similar to chromosome 4, for rings derived from chromosome 18, cytogenetically stable ( e.g., present two cases) and unstable rings [ 19 ] are reported. Eight cases with were characterized in the present study (cases R-13 to R-20). While cases R-13 to R-15 were unbalanced and led to clinical signs, two of the cases just detected were due to infertility (R-17 and R-20). As reported in [ 20 ] , most, if not all ring chromosome 21 cases are mosaic, as the ones here described. A ring chromosome 21 syndrome was also postulated [ 21 ] . The three cases were either cytogenetically stable (R-21 and R-22) or unstable (R-23). The reason for the cytogenetic study was available only for case R-21; it was infertility, and in the literature there are several similar cases reported [ 22 ] . Turner syndrome is cytogenetically characterized by karyotype 45,X; in ∼5.0% of the cases, this main cell line is accompanied by a second one having 46 chromosomes due to an additional derivative X- or Y-chromosome [ 23 ] . Here, six such cases were characterized in more detail, as they had a ring derived from the (cases R-24 to R-28) or the (R-29). Interestingly, all cases were detected during adulthood and only two of them due to a suspicion of Turner syndrome (R-24 and R-26). The majority of the cases were referred due to infertility.

Ring Chromosome-Induced Imbalances

In all 29 studied ring chromosome cases ( Table 1 ), euchromatic imbalances were present except for cases R-7, R-21 and R-22. In the latter, clinical data was available only for case R-21, and infertility was the only clinical problem observed there. Primarily, case R-2 did not have any imbalance due to a ring chromosome, but double ring formation and loss of the ring chromosome led to a partial tri - or monosomy in 23.0% of the patient’s cells overall. Imbalances were exclusively induced by the ring chromosome formation in case R-10. Moreover, in all the remaining 24 cases, imbalances were also caused by secondary effects of the ring chromosome formation: double ring formation: R-1, R-3 to R-5, R-8, R-15, R-16, R-18 to R-20, R-23, R-28 and R-29; ring doubling: R-1, R-15, R-26 and R-28; complex changes of the ring itself: R-1, R-15 to R-17 and R-23; ring opening (including further rearrangements): R-1, R-8, R-11, R-13, R-15, R-17, R-19, R-20 and R-23; loss of the ring: R-1, R-4, R-6, R-8, R-9, R-12 to R-16, R-19 and R-24 to R-29. Similar observations were also made for other ring chromosomes 22. The idea that there might even be a “ring syndrome” irrespective of the chromosomal origin of the ring [ 24 ] might be due to the gross imbalances induced by these secondary changes [ 25 ] .

CONCLUSIONS

In general, this report supports the idea that ring chromosome patients fall into two groups: a larger one with (severe) clinical signs and symptoms due to the ring chromosome and a smaller one with no obvious clinical problems apart from infertility. The latter can be due to gamete instability at meiosis due to the ring chromosome which leads to an increased breakdown [ 22 ] . This cytogenetic study of 29 rings also shows that chromosomal imbalances are secondary inducings in ∼85.0% of the cases by loss of the ring (68.0%), double ring formation (52.0%), ring opening (36.0%), ring doubling (16.0%) and complex changes of the ring itself (16.0%).
  24 in total

1.  Clinical and molecular-cytogenetic studies in seven patients with ring chromosome 18.

Authors:  P Stankiewicz; I Brozek; Z Hélias-Rodzewicz; J Wierzba; J Pilch; E Bocian; A Balcerska; A Wozniak; I Kardaś; J Wirth; T Mazurczak; J Limon
Journal:  Am J Med Genet       Date:  2001-07-01

2.  Mosaic ring chromosome 21, monosomy 21, and isodicentric ring chromosome 21: prenatal diagnosis, molecular cytogenetic characterization, and association with 2-Mb deletion of 21q21.1-q21.2 and 5-Mb deletion of 21q22.3.

Authors:  Chih-Ping Chen; Yi-Hui Lin; Szu-Yuan Chou; Yi-Ning Su; Schu-Rern Chern; Yu-Ting Chen; Dai-Dyi Town; Wen-Lin Chen; Wayseen Wang
Journal:  Taiwan J Obstet Gynecol       Date:  2012-03       Impact factor: 1.705

3.  Three unusual but cytogenetically similar cases with up to five different cell lines involving structural and numerical abnormalities of chromosome 18.

Authors:  Isabel M Carreira; Alexandra Mascarenhas; Eunice Matoso; Ana B Couceiro; Lina Ramos; Andreas Dufke; Marie Mazauric; Rüdiger Stressig; Nadezda Kosyakova; Joana B Melo; Thomas Liehr
Journal:  J Histochem Cytochem       Date:  2007-06-26       Impact factor: 2.479

4.  Severe phenotype resulting from an active ring X chromosome in a female with a complex karyotype: characterisation and replication study.

Authors:  C Stavropoulou; C Mignon; B Delobel; A Moncla; D Depetris; M F Croquette; M G Mattei
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

5.  Mechanisms of ring chromosome formation, ring instability and clinical consequences.

Authors:  Roberta S Guilherme; Vera F Ayres Meloni; Chong A Kim; Renata Pellegrino; Sylvia S Takeno; Nancy B Spinner; Laura K Conlin; Denise M Christofolini; Leslie D Kulikowski; Maria I Melaragno
Journal:  BMC Med Genet       Date:  2011-12-21       Impact factor: 2.103

6.  The cytogenetic and clinical implications of a ring chromosome 2.

Authors:  G B Cote; A Katsantoni; D Deligeorgis
Journal:  Ann Genet       Date:  1981

7.  Multicolor chromosome banding (MCB) with YAC/BAC-based probes and region-specific microdissection DNA libraries.

Authors:  T Liehr; A Weise; A Heller; H Starke; K Mrasek; A Kuechler; H-U G Weier; U Claussen
Journal:  Cytogenet Genome Res       Date:  2002       Impact factor: 1.636

8.  Chromosome r(10)(p15.3q26.12) in a newborn child: case report.

Authors:  Cecilia Gunnarsson; Barbara Graffmann; Jon Jonasson
Journal:  Mol Cytogenet       Date:  2009-12-07       Impact factor: 2.009

9.  Does "ring syndrome" exist? An analysis of 207 case reports on patients with a ring autosome.

Authors:  G Kosztolányi
Journal:  Hum Genet       Date:  1987-02       Impact factor: 4.132

Review 10.  Small supernumerary marker chromosomes (sSMC) in humans.

Authors:  T Liehr; U Claussen; H Starke
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

View more
  10 in total

Review 1.  Neurodevelopmental copy-number variants: A roadmap to improving outcomes by uniting patient advocates, researchers, and clinicians for collective impact.

Authors: 
Journal:  Am J Hum Genet       Date:  2022-08-04       Impact factor: 11.043

2.  Ring Chromosome 17 Not Involving the Miller-Dieker Region: A Case with Drug-Resistant Epilepsy.

Authors:  Antonietta Coppola; Deborah Morrogh; Fiona Farrell; Simona Balestrini; Laura Hernandez-Hernandez; S Krithika; Josemir W Sander; Jonathan J Waters; Sanjay M Sisodiya
Journal:  Mol Syndromol       Date:  2017-09-15

3.  Duplication of Yq- and proximal Yp-arms with deletion of almost all PAR1 (including SHOX) in a young man with non-obstructive azoospermia, short stature and skeletal defects.

Authors:  Dino Cancemi; Alessandra Iannuzzi; Angela Perucatti; Luigi Montano; Oronzo Capozzi; Carmine Spampanato; Maria Luisa Ventruto; Maria Urciuoli; Leopoldo Iannuzzi; Valerio Ventruto
Journal:  J Appl Genet       Date:  2017-10-06       Impact factor: 3.240

4.  Molecular cytogenetic characterization of two Turner syndrome patients with mosaic ring X chromosome.

Authors:  Pooja Chauhan; Sushil Kumar Jaiswal; Anjali Rani Lakhotia; Amit Kumar Rai
Journal:  J Assist Reprod Genet       Date:  2016-07-07       Impact factor: 3.412

5.  Chromosome passenger complex is required for the survival of cells with ring chromosomes in fission yeast.

Authors:  Ahmed G K Habib; Kanako Sugiura; Masaru Ueno
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

Review 6.  Mosaicism for structural non-centromeric autosomal rearrangements in disease-defined carriers: sex differences in the rearrangements profile and maternal age distributions.

Authors:  Natalia V Kovaleva; Philip D Cotter
Journal:  Mol Cytogenet       Date:  2017-05-19       Impact factor: 2.009

Review 7.  Human ring chromosome registry for cases in the Chinese population: re-emphasizing Cytogenomic and clinical heterogeneity and reviewing diagnostic and treatment strategies.

Authors:  Qiping Hu; Hongyan Chai; Wei Shu; Peining Li
Journal:  Mol Cytogenet       Date:  2018-02-27       Impact factor: 2.009

Review 8.  Factors affecting clinical manifestation of chromosomal imbalance in carriers of segmental autosomal mosaicism: differential impact of gender.

Authors:  Natalia V Kovaleva; Philip D Cotter
Journal:  J Appl Genet       Date:  2022-01-01       Impact factor: 3.240

Review 9.  The past, present, and future for constitutional ring chromosomes: A report of the international consortium for human ring chromosomes.

Authors:  Peining Li; Barbara Dupont; Qiping Hu; Marco Crimi; Yiping Shen; Igor Lebedev; Thomas Liehr
Journal:  HGG Adv       Date:  2022-09-10

10.  Genetic Testing in Patients with Neurodevelopmental Disorders: Experience of 511 Patients at Cincinnati Children's Hospital Medical Center.

Authors:  Xiaoli Du; Jennifer Elaine Glass; Stephanie Balow; Lisa M Dyer; Pamela A Rathbun; Qiaoning Guan; Jie Liu; Yaning Wu; D Brian Dawson; Lauren Walters-Sen; Teresa A Smolarek; Wenying Zhang
Journal:  J Autism Dev Disord       Date:  2021-11-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.